105 CMR, § 720.083
Current through Register 1533, October 25, 2024
Upon completion of the review of all relevant information, including petitions, by the Commission, the Department shall propose amendments to the List of Interchangeable Drug Products by issuing a Notice of Public Comment Period pursuant to M.G.L. c. 30A, §§ 2 and 3. The Department shall mail a Notice of Public Comment Period to each person who filed a petition during the period ending 30 days before the Notice of Public Comment Period is issued. In addition, the Department shall mail a Notice of the Public Comment Period to each person who has filed a written request therefore with the Department during December of the previous year pursuant to M.G.L. c. 30A, § 2.
105 CMR, § 720.083